Clinical Trials Logo

Clinical Trial Summary

The investigational device is an approved femtosecond laser (FSL) device with an integrated imaging system to perform certain steps of the cataract procedure. The FSL will perform anterior capsulotomy and lens fragmentation in individuals suffering from age-related cataract with need of cataract surgery.

Cataract surgery will be performed in subjects who have signed an informed consent form. Aqueous humor will be collected and screening will be performed for Total Prostaglandin and Prostaglandin E2 via en-bloc Enzyme-linked Immunosorbent Assay (ELISA)-Kit.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03390400
Study type Interventional
Source Medical University of Vienna
Contact
Status Active, not recruiting
Phase N/A
Start date May 29, 2017
Completion date March 14, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT06053554 - Outcome of Two Surgical Methods for IOLImplantation in Eyes With Pseudoexfoliation Syndrome N/A
Completed NCT03903965 - Comparison of Retinal Perfusion Between Diabetic and Non-diabetic Patients With OCT Angiography After Cataract Surgery.
Completed NCT04196673 - Posterior Capsule Opafication of Two Different Hydrophobic Acrylic Intraocular Lenses N/A
Recruiting NCT03525015 - Impact of a Printed Decision Aid on Cataract Surgery Choice N/A
Active, not recruiting NCT03465124 - Evaluation of Central Macular Thickness in Femtosecond Laser-assisted Cataract Surgery N/A
Not yet recruiting NCT04230629 - Evaluation of Physiological Responses at the Anterior Surface of Two (Hydrophobic Acrylic) Intraocular Lens Models N/A
Recruiting NCT04321226 - Femtosecond Laser-assisted Astigmatism Treatment Phase 4
Recruiting NCT03803852 - Rotation of Hydrophobic Acrylic Lenses - Rayner RA0800C & Alcon Clareon & Hoya Nanex & Hoya Vivinex XY1-EM & RayOne EMV Toric N/A
Active, not recruiting NCT04369482 - Posterior Capsule Opafication of Different Hydrophobic Acrylic Intraocular Lenses: Vivinex iSert P261 vs.Clareon IOL N/A
Completed NCT06365762 - The Safety and Efficacy Study of Ethylenediaminetetraacetic Acid (EDTA) Ophthalmic Solution in Patients With Loss of Contrast Sensitivity Due to Age-Related, Low-Grade Nuclear Cataract Phase 1/Phase 2
Recruiting NCT05822089 - Intraindividual Comparison of EMO IOLs N/A
Completed NCT03390361 - Release of Proinflammatory Cytokines (IL-1β, IL-6) and Total-prostaglandin (PG) Following Femtosecond Laser-assisted Cataract Surgery Compared to Manual Cataract Surgery N/A